Patients with atopic dermatitis (AD) are at a higher risk for developing ocular surface disease (OSD) relative to the general population, and OSD may be exacerbated with the use of type 2 inflammation-inhibiting biologics.

An increased awareness is needed amongst dermatology providers on how OSD may present as well as appropriate care options for patients with AD.

It is important for dermatology providers to proactively build a partnership with an eye care specialist to enable prompt referral to eye care specialists when needed.